Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
84.49
+0.13 (0.15%)
Aug 12, 2026, 11:45 AM EDT - Market open
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $8.96 billion as of August 12, 2026. Its market cap has increased by 247.52% in one year.
Market Cap
8.96B
Enterprise Value
7.80B
1-Year Change
247.52%
Ranking
Category
Stock Price
$84.49
ChartMarket Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $539.40M to $8.96B, an increase of 1,561.28%. That is a compound annual growth rate of 41.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 8.96B | 102.86% |
| Dec 31, 2025 | 4.42B | -6.84% |
| Dec 31, 2024 | 4.74B | 99.51% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.70M | -27.03% |
| Dec 31, 2021 | 1.35B | 190.53% |
| Dec 31, 2020 | 464.50M | -23.56% |
| Dec 31, 2019 | 607.70M | -15.70% |
| Dec 31, 2018 | 720.90M | 33.65% |
| Jul 18, 2018 | 539.40M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 10.12B |
| Praxis Precision Medicines | 10.07B |
| Krystal Biotech | 9.66B |
| Protagonist Therapeutics | 9.44B |
| Ionis Pharmaceuticals | 9.40B |
| Spyre Therapeutics | 9.25B |
| Kymera Therapeutics | 8.94B |
| Vaxcyte | 8.64B |